Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Analgesic Effect of Inhaled Lavender Essential Oil for Clipping of Tongue-ties (LEO-SME1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04877392
Recruitment Status : Completed
First Posted : May 7, 2021
Last Update Posted : January 28, 2022
Sponsor:
Information provided by (Responsible Party):
Parc de Salut Mar

Brief Summary:
Clipping of the tongue-tie is a common procedure that neonatologists perform in our neonatal unit to help establish breastfeeding. It is a painful technique where the measures healthcare providers usually perform to control pain (such as sucking) cannot be done at the time of the clipping because the technique is performed on the tongue. The aim of this study was to prove that inhaled lavender essential oil during the clipping of the tongue-tie can help control pain. Participants were newborns born at our hospital during the study period. They were offered to participate and enrolled in the study if their parents agreed to and signed an informed consent. The use of inhaled lavender essential oil is safe. No side effects have been found with its use. The procedure of the frenotomy did not change for patients who were enrolled in the study. By demonstrating that inhaled lavender essential oil helps reduce pain, its use was included as part of the regular measures to control pain during frenotomies at our neonatal unit (Hospital del Mar, Barcelona, Spain). The study started in August 2020 and ended in April 2021.

Condition or disease Intervention/treatment Phase
Ankyloglossia Dietary Supplement: Lavender essential oil Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 142 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Supportive Care
Official Title: Analgesic Effect of Inhaled Lavender Essential Oil for Frenotomy in Healthy Neonates: a Randomized Clinical Trial
Actual Study Start Date : August 18, 2020
Actual Primary Completion Date : April 15, 2021
Actual Study Completion Date : April 15, 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
No Intervention: Control (usual measures to control pain)
The neonate was taken to the neonatal unit and monitored with a pulse-oximeter before, during and after the procedure. The neonate was swaddled, administered 1 mL of oral sucrose, and allowed to suck for 2 minutes prior to the procedure.
Experimental: Case (usual measures to control pain plus inhaled lavender essential oil)
The neonate was taken to the neonatal unit and monitored with a pulse-oximeter before, during and after the procedure. The neonate was swaddled, administered 1 mL of oral sucrose, and allowed to suck for 2 minutes prior to the procedure. The neonate also had a 7 x 7 cm gauze pad with 1 drop (43.75 mg) of 100% pure LEO (Pranarôm España S.L.) placed 2 cm under their nose for 2 minutes prior to starting the frenotomy and for the duration of the procedure.
Dietary Supplement: Lavender essential oil
Use of inhaled lavender essential oil




Primary Outcome Measures :
  1. Crying length [ Time Frame: Up to 5 minutes post-procedure ]
    Crying length after the frenotomy in seconds

  2. NIPS score [ Time Frame: Up to 5 minutes post-procedure ]
    Neonatal Infant Pain Score value (0-7). NIPS evaluates facial expression, crying, breathing pattern, arm and leg position, and state of arousal on a scale from 0 to 7, where 0-2 means no pain to mild pain, 3-4 mild to moderate pain, and >4 severe pain.

  3. Change in heart rate [ Time Frame: Up to 5 minutes post-procedure ]
    Change in heart rate pre/post-procedure (beats per minute)

  4. Change in oxygen saturation [ Time Frame: Up to 5 minutes post-procedure ]
    Change in oxygen saturation (%)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 15 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Healthy full-term neonates born at Hospital del Mar (Barcelona, Spain), or less than 15 days old who had been discharged and returned for the frenotomy, who underwent a frenotomy for type 3 tongue-ties according to Coryllos classification and the Hazelbaker tool during the study period (August 2020 to April 2021)

Exclusion Criteria:

  • Refusal of the patient's parents to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04877392


Locations
Layout table for location information
Spain
Hospital del Mar
Barcelona, Spain, 08003
Sponsors and Collaborators
Parc de Salut Mar
Investigators
Layout table for investigator information
Principal Investigator: Montserrat Fàbregas-Mitjans, Ph.D. Hospital del Mar
Publications of Results:

Other Publications:

Layout table for additonal information
Responsible Party: Parc de Salut Mar
ClinicalTrials.gov Identifier: NCT04877392    
Other Study ID Numbers: 2020/9373/I
First Posted: May 7, 2021    Key Record Dates
Last Update Posted: January 28, 2022
Last Verified: April 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Keywords provided by Parc de Salut Mar:
ankyloglossia
tongue-tie
aromatherapy
lavender
pain
neonate
Additional relevant MeSH terms:
Layout table for MeSH terms
Ankyloglossia
Stomatognathic Diseases